Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
drugs
4
×
fda
indiana blog main
indiana top stories
life sciences
national
4
×
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
cancer
deals
eli lilly
investing
medical device
merck
roche
startups
teva pharmaceutical
4d molecular therapeutics
What
fda
4
×
drug
approved
bio
companies
drugs
new
roundup
ahead
approval
arguments
asco
big
branded
cancer
choices
class
commercialized
commissioner
competitors
consumers
costly
counterweight
decades
deeper
digital
disease
dna
elevatebio
epidemic
fatty
fingerprint
frenzied
generic
genetic
going
graft
growing
known
led
Language
Current search:
drugs
×
national
×
fda
×
@xconomy.com
4 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
